STANDARDIZATION OF CATIONIC DERIVATIVE OF BAKTERIOPURPURINIMID AS PHARMACEUTICAL SUBSTANCE FOR ANTIMICROBIAL PHOTODYNAMIC THERAPYA

STANDARDIZATION OF CATIONIC DERIVATIVE OF BAKTERIOPURPURINIMID AS PHARMACEUTICAL SUBSTANCE FOR ANTIMICROBIAL PHOTODYNAMIC THERAPYA

In this paper key indicators due to Pharmacopoeia XIII [1] that can be used to standardize the cationic derivative of bakteriopurpurinimid as pharmaceutical substance (PS) are presented. The prime application of this compound to be a photosensitiser for antimicrobial photodynamic therapy (PDT).

Bibliographic Details
Main Authors: A. M. Frolova, D. A. Grafov, V. S. Tukova, E. V. Vorfolomeeva, N. A. Keryanov, E. V. Feelonenko, A. V. Panov, M. A. Green, S. A. Kedeek
Format: Article
Language:Russian
Published: LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2019-01-01
Series:Разработка и регистрация лекарственных средств
Subjects:
standardization
quality control
pharmaceutical substance
antimicrobial photodynamic therapy
cationicderivative
bakteriopurpurinimid
Online Access:https://www.pharmjournal.ru/jour/article/view/320

Internet

https://www.pharmjournal.ru/jour/article/view/320

Similar Items